Morie Gertz

Morie Gertz, a leading amyloidosis expert from the Mayo Clinic, discusses the complex world of diagnosing this rare disease. He highlights early signs often missed by clinicians and elaborates on the key differences between light chain and ATTR subtypes. The conversation dives into diagnostic challenges, the role of advanced imaging, and the importance of a holistic approach to patient care. Gertz also explores emerging therapies and the significance of timely diagnosis to prevent irreversible organ damage.